FIFTH HOUSE OF CREATIVITY INC.

Abstract
IRIS LUX™ is the world’s first sovereign imaging system engineered to capture and archive rare-spectrum eyes—amber, red, orange, violet, and bioluminescent tones. Where conventional optics distort or flatten, IRIS LUX preserves glow, clarity, and spiritual integrity. Through its custom lens kit, spectrum-balanced ringlight, AI-powered capture software, and sovereign iris registry, it redefines visual sovereignty: protecting identity, affirming rare-spectrum beauty, and securing biometric dignity.

---

Assertions

• First global framework dedicated to glowing, rare-spectrum irises.
• Lens, ringlight, software, and registry system designed for biometric truth + artistic fidelity.
• Phase I R&D funded through Fifth House IP Development Fund + estate budgets.
• Declared core valuation in the multi-million CAD range (2025).
• Forecasted 5–10 year yield in the billion-dollar range, scaling globally.
• Primary rollout at Pleasant House studios; global licensing to follow.

---

Mechanics (Public Facing)

• Lens Kit™: DSLR/mirrorless-compatible, spectrum-tuned optics.
• Ringlight™: Golden-hour balanced, warm-spectrum, near-IR calibrated.
• Capture Software™: Real-time AI glow mapping, tone lock, sovereign metadata embed.
• Surveillance Mode™: Consent-based biometric overlay for sovereign CCTV upgrades.
• Sovereign Iris Registry™: Encrypted, AI-scrape-proof archive protecting portraits.

---

Valuation (Hardened)

• System Value (2025): declared in the multi-million CAD range.
• 5–10 Year IP Yield: projected at billion-dollar scale.
• Phase I Budget: covered under <$100K CAD initial R&D.

---

Monetization

• Lens Kit retail, Ringlight, Capture App, and Surveillance Protocol units.
• Portraiture sessions bundled with sovereign archiving.
• Forecasted 5-year install base: hundreds of thousands of systems.
• Secondary markets: holography, art licensing, biometric archiving.

---

Governance

• Ledgered under Fifth House of Creativity Inc.
• 100% IP ownership retained by Amethyst Amaris.

---

Compliance

• No biometric data sales.
• Registry opt-in only; encrypted archival.
• Treaty-level IP protections underway.

---

Risks & Mitigations

• Market unfamiliarity → countered by luxury positioning + sovereign framing.
• Privacy concerns → mitigated with encrypted registry and explicit consent structure.

---

Evidence

• Filed May 30, 2025.
• R&D Phase I launched.
• Pilot portrait sessions underway at Pleasant House.

---

Changelog

v1.0 — June 2025: Ledgered filing complete.